Vaccination and Control Methods of West Nile Virus Infection in Equids and Humans
Open Access
Abstract
West Nile virus (WNV) is capable of causing severe neurologic disease in both humans and equines, making it a disease of importance in both human medicine and veterinary medicine. No targeted treatments exist for WNV infection in either humans or equines. Infection is treated symptomatically through management of symptoms like fever and seizures. As treatment for WNV is purely supportive, the response to WNV has focused primarily on methods of disease prevention. To this end, research efforts have yielded several effective vaccines for equine use as well as numerous conventional mosquito control techniques. Even with the implementation of these techniques, disease caused by WNV remains a concern since no human vaccine exists. Due to the lack of a human vaccine, novel preventative strategies are under active research and development. Of these strategies, some of the most conceptually promising are techniques using genetically modified mosquitoes, addressing the disease at the vector level with minimal ecological side effects. Taken together, the use of combined, synergistic methods, such as physical barriers, transgenic mosquitoes, and immunological targets, will be the best way to prevent WNV disease.Keywords
Funding Information
- College of Veterinary Medicine, Washington State University
This publication has 60 references indexed in Scilit:
- Regulatory and policy considerations for the implementation of gene drive-modified mosquitoes to prevent malaria transmissionTransgenic Research, 2023
- A systematic review of environmental factors related to WNV circulation in European and Mediterranean countriesOne Health, 2023
- Insulin Potentiates JAK/STAT Signaling to Broadly Inhibit Flavivirus Replication in Insect VectorsCell Reports, 2019
- An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adultsVaccine, 2019
- Transgenic Mosquitoes – Fact or Fiction?Trends in Parasitology, 2018
- Cost effectiveness of a targeted age-based West Nile virus vaccination programVaccine, 2017
- Enhancing vaccine safety capacity globally: A lifecycle perspectiveVaccine, 2015
- The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteersVaccine, 2013
- Naturally Induced Humoral Immunity to West Nile Virus Infection in RaptorsEcohealth, 2008
- Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infectionVaccine, 2007